Drug Retail

According to Goldman Sachs, Walgreen (NYSE: WAG) price target is decreased to $47. Goldman Sachs said that WAG's underlying May quarter results exceeded our expectation, with EBIT beating our forecast in high-quality fashion, as gross margin rate exceeded our estimate despite input cost pressures...

According to Citi, Walgreen (NYSE: WAG) reported F3Q11 EPS of $0.65 per diluted share, above its estimate of $0.63, above consensus of $0.62, and vs. $0.52 last year (excld. one-time items LY). Citi said that reported F3Q11 EPS included a (-$0.01)/share impact from restructuring and restructuring-...

Morgan Stanley reiterated its Neutral rating on Walgreen Company (NYSE: WAG). At the same time, Morgan Stanley left its price target unchanged at $43 after the company reported better than expected quarterly earnings results. In a research report published today, Morgan Stanley states, "WAG...

Jefferies reiterated its Buy rating on Walgreen (NYSE: WAG). At the same time, Jefferies left its price target on the company's stock unchanged at $50 after the company's reported better than expected quarterly earnings. In a research report published today, Jefferies states, "Walgreens reported...

Goldman Sachs has lowered the price target on Walgreen Company (NYSE: WAG) from $48 to $47 and maintains its Buy rating.

Stocks surged Tuesday as optimism over the Greece crisis unleashed some pent-up buying power. At day's end, the Nasdaq scored a 2.2% gain. The NYSE composite jumped 1.5%, and the S&P 500 swelled 1.3%. Volume increased on the Nasdaq and NYSE compared with Monday's light action. Winners swamped...

Cusick's Corner Plop, Plop, Fizz, Fizz, - oh what a rally relief it is. The market has bubbled up and now pulled off the highs going into the Midday. The Housing data came in a little better than expected this morning but the market into the Midday hit resistance, 1291 on the S&P Continuous...

Express Scripts, Inc. (NASDAQ: ESRX) said today it is open to continued negotiations with Walgreens (NYSE: WAG) to make prescription drugs affordable and accessible for American families. "In these challenging economic times, it is critical that we all work together to keep medicines affordable...

Walgreen Company (NYSE: WAG) shares are down more than 4% today, after the company reported quarterly earnings this morning, and said that its deal with Express Scripts (NASDAQ: ESRX) would stop. Walgreen's reported third quarter earnings of 65 cents per share on $18.37 billion in revenues. Wall...

Walgreens (NYSE: WAG) is trading over 6% lower on the session on the news that the company has terminated the contract negotiations with Express Scripts, Inc. (NASDAQ: ESRX). The shares are currently trading at $42.34. Walgreen Co. together with its subsidiaries, operates a drugstore chain in the...

Shares of Walgreen Co (NYSE: WAG) dropped about 5.7% after the company reported a 30% rise in its fiscal third-quarter profit on Tuesday. Walgreen's quarterly profit surged to $603 million, or $0.65 per share, from $463 million, or $0.47 per share, in the year-earlier period. Its sales increased to...

Walgreen Co (NYSE: WAG) fell 5.05% to $42.90 in the pre-market session. WAG reported a 30% rise in its fiscal third-quarter profit Prospect Capital Corporation (NASDAQ: PSEC) dipped 4.49% to $10.20 in the pre-market session. PSEC reported that it is offering 10,000,000 shares of its common stock...

Morgan Stanley is out with its report today on CVS Caremark (NYSE: CVS), maintaining Equal-weight. In a note to clients, Morgan Stanley writes, "The California Public Employees' Retirement System announced after the close that it has awarded a 3 year contract worth $565M annually to CVS/ Caremark...

This is your Benzinga news summary and traders' outlook for Tuesday, June 21, 2011, covering headlines from overnight and Tuesday's pre-market session. Today in domestic pre-market trading, U.S. equity futures are trading higher as the U.S. dollar is slightly lower this morning on optimism of a...

Walgreen Co (NYSE: WAG) reported a 30% rise in its fiscal third-quarter profit on Tuesday. Walgreen's quarterly profit surged to $603 million, or $0.65 per share, from $463 million, or $0.47 per share, in the year-earlier period. Its sales increased to $18.37 billion from $17.2 billion. However,...